PERKINELMER INC (PKI) Stock Fundamental Analysis
USA - NYSE:PKI - US7140461093 - Common Stock
115.24 USD
-1.06 (-0.91%)
115.24 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to PKI. PKI was compared to 58 industry peers in the Life Sciences Tools & Services industry. While PKI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PKI is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
PKI had positive earnings in the past year.
In the past year PKI had a positive cash flow from operations.
In the past 5 years PKI has always been profitable.
In the past 5 years PKI always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 5.28%, PKI is doing good in the industry, outperforming 76.19% of the companies in the same industry.
The Return On Equity of PKI (10.11%) is better than 77.78% of its industry peers.
With a decent Return On Invested Capital value of 6.49%, PKI is doing good in the industry, outperforming 73.02% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PKI is significantly above the industry average of 13.50%.
The last Return On Invested Capital (6.49%) for PKI is well below the 3 year average (52.37%), which needs to be investigated, but indicates that PKI had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROIC | 6.49% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
1.3 Margins
PKI's Profit Margin of 16.32% is amongst the best of the industry. PKI outperforms 82.54% of its industry peers.
In the last couple of years the Profit Margin of PKI has grown nicely.
PKI has a Operating Margin of 23.43%. This is amongst the best in the industry. PKI outperforms 88.89% of its industry peers.
PKI's Operating Margin has improved in the last couple of years.
PKI has a better Gross Margin (58.39%) than 76.19% of its industry peers.
In the last couple of years the Gross Margin of PKI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% |
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PKI is creating value.
PKI has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for PKI has been reduced compared to a year ago.
2.2 Solvency
PKI has an Altman-Z score of 2.51. This is not the best score and indicates that PKI is in the grey zone with still only limited risk for bankruptcy at the moment.
PKI has a Altman-Z score (2.51) which is comparable to the rest of the industry.
PKI has a debt to FCF ratio of 7.40. This is a slightly negative value and a sign of low solvency as PKI would need 7.40 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 7.40, PKI is doing good in the industry, outperforming 77.78% of the companies in the same industry.
A Debt/Equity ratio of 0.53 indicates that PKI is somewhat dependend on debt financing.
The Debt to Equity ratio of PKI (0.53) is worse than 68.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Altman-Z | 2.51 |
ROIC/WACC0.65
WACC10.02%
2.3 Liquidity
A Current Ratio of 2.13 indicates that PKI has no problem at all paying its short term obligations.
PKI's Current ratio of 2.13 is on the low side compared to the rest of the industry. PKI is outperformed by 68.25% of its industry peers.
A Quick Ratio of 1.87 indicates that PKI should not have too much problems paying its short term obligations.
PKI has a worse Quick ratio (1.87) than 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 |
3. Growth
3.1 Past
PKI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.47%.
PKI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.15% yearly.
PKI shows a decrease in Revenue. In the last year, the revenue decreased by -3.37%.
The Revenue has been growing slightly by 7.97% on average over the past years.
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
3.2 Future
The Earnings Per Share is expected to grow by 6.04% on average over the next years.
Based on estimates for the next years, PKI will show a decrease in Revenue. The Revenue will decrease by -8.60% on average per year.
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.51, which indicates a correct valuation of PKI.
Based on the Price/Earnings ratio, PKI is valued cheaper than 96.83% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.13, PKI is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 22.11, the valuation of PKI can be described as rather expensive.
77.78% of the companies in the same industry are more expensive than PKI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of PKI to the average of the S&P500 Index (22.35), we can say PKI is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 |
4.2 Price Multiples
93.65% of the companies in the same industry are more expensive than PKI, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PKI indicates a rather cheap valuation: PKI is cheaper than 87.30% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.52 | ||
| EV/EBITDA | 12.35 |
4.3 Compensation for Growth
The excellent profitability rating of PKI may justify a higher PE ratio.
PKI's earnings are expected to decrease with -4.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
5. Dividend
5.1 Amount
No dividends for PKI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
115.24
-1.06 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners86.56%
Inst Owner Change0.17%
Ins Owners0.81%
Ins Owner Change0%
Market Cap14.57B
Revenue(TTM)4.57B
Net Income(TTM)746.14M
Analysts73
Price Target159.39 (38.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP4.74%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.02%
Min EPS beat(2)2.33%
Max EPS beat(2)3.7%
EPS beat(4)4
Avg EPS beat(4)8.57%
Min EPS beat(4)2.33%
Max EPS beat(4)14.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.78%
Min Revenue beat(2)-30.42%
Max Revenue beat(2)-29.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-30.42%
Max Revenue beat(4)52.86%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 | ||
| P/S | 3.19 | ||
| P/FCF | 24.52 | ||
| P/OCF | 21.43 | ||
| P/B | 1.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.35 |
EPS(TTM)7.94
EY6.89%
EPS(NY)5.21
Fwd EY4.52%
FCF(TTM)4.7
FCFY4.08%
OCF(TTM)5.38
OCFY4.67%
SpS36.16
BVpS58.4
TBVpS-19.59
PEG (NY)N/A
PEG (5Y)0.66
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROCE | N/A | ||
| ROIC | 6.49% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 35.96% | ||
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)8.57%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0.99%
ROICexgc growth 5Y-8%
ROICexc growth 3Y-3.25%
ROICexc growth 5Y0.67%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
F-Score7
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Debt/EBITDA | 2.93 | ||
| Cap/Depr | 20.05% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 79.63% | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 | ||
| Altman-Z | 2.51 |
F-Score7
WACC10.02%
ROIC/WACC0.65
Cap/Depr(3y)26.47%
Cap/Depr(5y)33.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)118.43%
Profit Quality(5y)114.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
EBIT growth 1Y-24.58%
EBIT growth 3Y25.31%
EBIT growth 5Y20.49%
EBIT Next Year-23.7%
EBIT Next 3Y-3.21%
EBIT Next 5Y3.97%
FCF growth 1Y-54.67%
FCF growth 3Y28.17%
FCF growth 5Y18.96%
OCF growth 1Y-51.81%
OCF growth 3Y23.2%
OCF growth 5Y18.7%
PERKINELMER INC / PKI FAQ
What is the ChartMill fundamental rating of PERKINELMER INC (PKI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to PKI.
What is the valuation status for PKI stock?
ChartMill assigns a valuation rating of 7 / 10 to PERKINELMER INC (PKI). This can be considered as Undervalued.
Can you provide the profitability details for PERKINELMER INC?
PERKINELMER INC (PKI) has a profitability rating of 3 / 10.
Can you provide the financial health for PKI stock?
The financial health rating of PERKINELMER INC (PKI) is 4 / 10.
Is the dividend of PERKINELMER INC sustainable?
The dividend rating of PERKINELMER INC (PKI) is 0 / 10 and the dividend payout ratio is 4.74%.